Hinokiflavone

CAS No. 19202-36-9

Hinokiflavone( —— )

Catalog No. M23871 CAS No. 19202-36-9

Hinokiflavone is a novel modulator of pre-mRNA splicing activity in vitro and in cellulo.?

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 102 In Stock
10MG 151 In Stock
25MG 255 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Hinokiflavone
  • Note
    Research use only, not for human use.
  • Brief Description
    Hinokiflavone is a novel modulator of pre-mRNA splicing activity in vitro and in cellulo.?
  • Description
    Hinokiflavone is a novel modulator of pre-mRNA splicing activity in vitro and in cellulo.?Hinokiflavone blocks splicing of pre-mRNA substrates by inhibiting spliceosome assembly, specifically preventing B complex formation.?Hinokiflavone is a SUMO protease inhibitor, inhibiting sentrin-specific protease 1 (SENP1) activity.Hinokiflavone has significant cytotoxicity, it has inhibition of MMP-9.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    MMP
  • Recptor
    MMP|bax|bcL-2
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    19202-36-9
  • Formula Weight
    538.5
  • Molecular Formula
    C30H18O10
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:10 mM
  • SMILES
    O=C1C=C(C2=CC=C(O)C=C2)OC3=CC(O)=C(OC4=CC=C(C5=CC(C6=C(O)C=C(O)C=C6O5)=O)C=C4)C(O)=C13
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Hinokiflavone, a cytotoxic principle from Rhus succedanea and the cytotoxicity of the related biflavonoids. Planta Med. 1989 Apr;55(2):166-8.
molnova catalog
related products
  • Fraxinellone

    Fraxinellone significantly reduced weight loss and diarrhea in mice and alleviated the macroscopic and microscopic signs of the disease.

  • AGPS-IN-2i

    AGPS-IN-2i is a potent and high-affinity inhibitor of alkylglycerol phosphate synthase that controls ether lipid utilization and metabolism in cells, reduces ether lipid levels and cell migration, and promotes proliferation and motility of cancer cells.

  • Ramelteon

    Ramelteon is the first in a new class of sleep agents that selectively binds to the melatonin receptors in the suprachiasmatic nucleus (SCN).